News & Events

Learn about what's new with CMC Biologics

CMC Biologics and OncoSynergy Enter into an Agreement for Accelerated Process Development and GMP Manufacture of an Investigational Drug to Combat Ebola


Experimental monoclonal antibody to be used in clinical trials with patients in West Africa infected with the Ebola virus. Recent data from the World Health Organization said the virus has infected 18,000 people, with a fatality rate greater than 60%.

Joseph Wypych, 20-year Biopharmaceutical Executive, Joins CMC Biologics as General Manager, Seattle Facility


Breadth and depth of leadership and commercial manufacturing experience a strong fit for company’s growth and culture

Seattle, Washington, USA – December 3, 2014 –
CMC Biologics, a leading contract manufacturing organization dedicated to technical excellence in process development and cGMP manufacture of therapeutic proteins, today announced that Joseph Wypych has joined the Company as General Manager of its Seattle facility. Mr. Wypych will manage site operations of CMC Biologics’ clinical and commercial manufacturing facility.

Follow Us
Join us on LinkedIn Follow us on Twitter